Sumit Sangwan's doping ban lifted, NADA panel rules intake of banned substance unintentional

Image
Press Trust of India New Delhi
Last Updated : Mar 02 2020 | 6:08 PM IST

The one-year doping ban on former Asian silver-medallist boxer Sumit Sangwan was on Monday lifted after he proved that his intake of a banned substance was unintentional in a hearing conducted by the National Anti-Doping Agency (NADA) here.

"Sumit has been cleared and his ban lifted as he has convinced the NADA panel that the diuretic he tested positive for was a case of unintentional intake," a Boxing Federation of India official told PTI.

Sangwan was banned for a year in December 2019 after testing positive for Acetazolamide, listed as a diuretic and masking agent under World Anti-Doping Agency's (WADA) 2019 Prohibited List.

"I am relieved, a huge weight is off my shoulders. I knew I wasn't in the wrong. I am glad I could prove myself," an emotional Sangwan said.

He had maintained that it was a case of unintentional intake as he had duly consulted a doctor before taking the medication for an eye infection.

The suspension, however, cost Sangwan dearly as the 2012 Olympian missed out on appearing for trials for this year's Tokyo Olympics.

Sangwan's sample was collected "out of competition" on October 10 last year.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 02 2020 | 6:08 PM IST

Next Story